Want to join the conversation?
$BSX said that in 1Q16 it received FDA approval for the ACUITY X4 Quadripolar Left Ventricular Leads, which enables the company to offer a full X4 CRT system, consisting of the device and the leads to the US market. $BSX launched AXIOS Stent and Electrocautery Enhanced Delivery System to help physicians manage two serious pancreatic complications.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)